back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-17 11:05 Tx date 2024-05-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Bryan, Christopher Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,870
+20,500 vol $0.14 each |
80,500 | |
| Filed 2024-05-14 16:31 Tx date 2024-05-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Bryan, Christopher Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,080
+9,000 vol $0.12 each |
60,000 | |
| Filed 2024-05-14 16:09 Tx date 2024-05-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Bryan, Christopher Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,320
+11,000 vol $0.12 each |
51,000 | |
| Filed 2024-05-13 11:34 Tx date 2024-05-10 |
$AGN
Algernon Pharmaceuticals Inc. |
Bryan, Christopher Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+20,000 vol $0.12 each |
40,000 | |
| Filed 2024-05-13 11:34 Tx date 2024-05-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bryan, Christopher Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,300
+20,000 vol $0.115 each |
20,000 | |
| Filed 2023-03-14 12:56 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+90,000 vol |
120,000 | |
| Filed 2023-03-14 12:55 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+30,000 vol |
104,000 | |
| Filed 2023-03-14 12:53 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+40,500 vol |
74,000 | |
| Filed 2023-03-14 12:52 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+7,500 vol |
33,500 | |
| Filed 2022-09-05 18:59 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+30,000 vol |
30,000 | |
| Filed 2022-09-05 18:58 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
26,000 | |
| Filed 2022-01-24 13:23 Tx date 2021-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-24 13:23 Tx date 2021-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-24 13:22 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,500 vol |
16,000 | |
| Filed 2022-01-24 13:21 Tx date 2021-11-23 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-247,500 vol |
2,500 | |
| Filed 2022-01-24 13:21 Tx date 2021-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2022-01-24 13:20 Tx date 2021-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|